Mouse model for noninvasive imaging of HIF prolyl hydroxylase activity: Assessment of an oral agent that stimulates erythropoietin production
Open accessThe DOI matches its Crossref record; 34 of the 35 references it cites were found in a registry or an index.
Abstract
Many human diseases are characterized by the development of tissue hypoxia. Inadequate oxygenation can cause cellular dysfunction and death. Tissues use many strategies, including induction of angiogenesis and alterations in metabolism, to survive under hypoxic conditions. The heterodimeric transcription factor hypoxia-inducible factor (HIF) is a master regulator of genes that promote adaptation to hypoxia. HIF activity is linked to oxygen availability because members of the EGLN family hydroxylate HIFalpha subunits on specific prolyl residues when oxygen is present, which marks them for ubiquitination and proteasomal degradation. We created a mouse that ubiquitously expresses a bioluminescent reporter consisting of firefly luciferase fused to a region of HIF that is sufficient for oxygen-dependent degradation. Our validation studies suggest that this mouse will be useful for monitoring hypoxic tissues and evaluating therapeutic agents that stabilize HIF. One such agent, the HIF prolyl hydroxylase inhibitor FG-4383, was active in the liver and kidney after systemic administration as determined by bioluminescence imaging, transcription profiling, and production of erythropoietin, indicating that the HIF transcriptional program can be manipulated in vivo with orally active organic small molecules.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“LPS-induced PHD inhibition was confirmed in DC derived from genetically engineered mice having the ODD domain fused to a luciferase gene (ODD-Luc; Safran et al., 2006).”
From Ferritin-Mediated Iron Sequestration Stabilizes Hypoxia-Inducible Factor-1α upon LPS Activation in the Presence of Ample Oxygen (2015) · cites this paper as Safran et al., 2006
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jaakkola, P., Mole, D. R., Tian, Y.-M., Wilson, M. I., Gielbert, J., Gaskell, S. J., Kriegsheim, A. V., Hebestreit, H. F., Mukherji, M., Schofield, C. J., et al. (2001) · Science · doi:10.1126/science.1059796 · Cited by 5,535
Generalized lacZ expression with the ROSA26 Cre reporter strain
Soriano, P. (1999) · Nature Genetics · doi:10.1038/5007 · Cited by 4,859
HIFα Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O 2 Sensing
Ivan, M., Kondo, K., Yang, H., Kim, W., Valiando, J., Ohh, M., Salic, A., Asara, J. M., Lane, W. S., & Kaelin Jr., W. G. (2001) · Science · doi:10.1126/science.1059817 · Cited by 4,735
Self-citationCre reporter strains produced by targeted insertion of EYFP and ECFP into the ROSA26 locus
Srinivas, S., Watanabe, T., Lin, C.-S., William, C. M., Tanabe, Y., Jessell, T. M., & Costantini, F. (2001) · BMC Developmental Biology · doi:10.1186/1471-213x-1-4 · Cited by 3,121
Huang, L. E., Gu, J., Schau, M., & Bunn, H. F. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.14.7987 · Cited by 2,113
Oxygen sensing by HIF hydroxylases
Schofield, C. J., & Ratcliffe, P. J. (2004) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1366 · Cited by 2,068
Shedding light onto live molecular targets
Weissleder, R., & Ntziachristos, V. (2003) · Nature Medicine · doi:10.1038/nm0103-123 · Cited by 1,909
Hypoxia of the Renal Medulla — Its Implications for Disease
Brezis, M., & Rosen, S. (1995) · New England Journal of Medicine · doi:10.1056/nejm199503093321006 · Cited by 1,222
Role of the kidney in erythropoiesis
JACOBSON, L. O., GOLDWASSER, E., FRIED, W., & PLZAK, L. (1957) · Nature · doi:10.1038/179633a0 · Cited by 862
Structure of the VHL-ElonginC-ElonginB Complex: Implications for VHL Tumor Suppressor Function
Stebbins, C. E., Kaelin, W. G., & Pavletich, N. P. (1999) · Science · doi:10.1126/science.284.5413.455 · Cited by 860
Self-citation
Research works printed but not linked: 2
- Zhong, Z., Arteel, G. E., Connor, H. D., Yin, M., Frankenberg, M. V., Stachlewitz, R. F., Raleigh, J. A., Mason, R. P. & Thurman, R. G. (1998) Am. J. Physiol. 275, F595–F604. [DOI] [PubMed] [Google Scholar]
- Heyman, S. N., Rosen, S. & Brezis, M. (1997) Blood Purif. 15, 232–242. [DOI] [PubMed] [Google Scholar]
Cited by
Items 301–322 of 322
Müller, R. (2020) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.726175911.793572472
Mechanisms of Toxicity, Carcinogenesis, Cancer Prevention and Cancer Therapy
(2006) · Toxicologic Pathology · doi:10.1080/01926230601120134
Efficacy of HIF-PH inhibitors in the treatment for renal anemia
坂下, 碧., & 南学, 正. (2022) · Nippon Ronen Igakkai Zasshi Japanese Journal of Geriatrics · doi:10.3143/geriatrics.59.263
Lu, X., Yan, C. H., Yuan, M., Wei, Y., Hu, G., & Kang, Y. (2023) · doi:10.1158/0008-5472.22382481
Dugbartey, G. J. (2023) · Springer eBooks · doi:10.1007/978-3-031-44041-0_3
Liang, L., Ueda, K., Ogura, S., & Shimosawa, T. (2024) · Life · doi:10.3390/life14101229
“Compared to other organs, the oxygen content in the kidney is relatively low, making it more responsive to further reductions in oxygen supply [6,7].”
BackgroundCampla, C. K., Hoppe, G., Yu, M., Woda, J. M., Peachey, N. S., Josyula, V. P., Stauffer, S. R., & Sears, J. E. (2025) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.4c02186
Nomura, K., Tanida, M., Akai, R., Yabe, T., Fujii, A., Nomura, K., Okada, K., Okino, K., Hayashi, N., Fujimoto, K., et al. (2025) · Physiological Reports · doi:10.14814/phy2.70648
“Four groups were studied ( n = 4 per group): Saline, Vasopressin, Treadmill + Vasopressin, and Hypoxia (8% O₂; positive control for 24 h) (Safran et al., 2006).”
Zhang, H., Xia, N., Tang, T., 聂少芳, Zha, L., Zhang, M., Lv, B., Lu, Y., Jiao, J., Li, J., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26578121
DAPK3 Suppresses Mammary Acini Morphogenesis and is Required for Mouse Development
Kocher, B. (2014) · Open Scholarship Institutional Repository (Washington University in St. Louis) · doi:10.7936/k70p0x26
Zhang, H., Xia, N., Tang, T., 聂少芳, Zha, L., Zhang, M., Lv, B., Lu, Y., Jiao, J., Li, J., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26578100
Understanding The Pathogenesis Of Renal Medullary Carcinoma
Soeung, M. (2021) · Digital Commons-TMC (Texas Medical Center)
Investigation of Neutrophil Swarming to Mycobacterium marinum Infection in Zebrafish
Oskam, J. J. M. (2024) · White Rose eTheses Online (University of Leeds, The University of Sheffield, University of York)
Enzymmodellkomplexe und PHD2-Inhibitoren
Brötsch, M. (2025) · doi:10.25593/open-fau-2321
低酸素誘導因子活性を有する腫瘍内浸潤細胞のin vivo光イメージング
宮原, 瞳., & Miyabara, H. (2025) · Institutional Repositories DataBase (IRDB)
Les cellules MAIT et la riboflavine dans les interactions hôte-microbiote
Morr, Y. E. (2021) · theses.fr (ABES) · doi:10.70675/c6a9fb38zefecz4f2ez8e2fz84c7e5f828dc
Mitchell, R. A., Xu, M., Hudson, E., Taylor, M. S., Hill, B. G., McClain, C. J., & Song, M. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.06.07.729655
低酸素誘導因子活性を有する腫瘍内浸潤細胞のin vivo光イメージング
Miyabara, H. (2025) · Institutional Repositories DataBase (IRDB)
Metadata
- Authors
- Safran, M., Kim, W. Y., O'Connell, F., Flippin, L., Günzler, V., Horner, J. W., DePinho, R. A., & Kaelin, W. G.
- Affiliations
- Brigham and Women's Hospital (US)
- Department of Medical Oncology, Dana–Farber Cancer Institute, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115; FibroGen, Inc., South San Francisco, CA 94080; and Howard Hughes Medical Institute, Chevy Chase, MD 20815
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2005-12-22
- Volume
- 103
- Issue
- 1
- Pages
- 105-110
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC1324998
- OpenAlex
- W1992933063
- Cited by
- 305
- References
- 35
- Citations by year
- 2026: 2 · 2025: 9 · 2024: 9 · 2023: 9 · 2022: 13 · 2021: 13 · 2020: 20 · 2019: 19 · 2018: 20 · 2017: 15 · 2016: 14 · 2015: 16 · 2014: 21 · 2013: 15 · 2012: 17
- FWCI
- 4.17
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- FibroGen
- National Institutes of Health
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Health Sciences › Medicine › Hematology › Erythropoietin and Anemia Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Kruppel-like factors research
- Keywords
- hypoxia-inducible factor, HIF prolyl hydroxylase, HIF prolyl hydroxylase inhibitors, tissue hypoxia, bioluminescence reporter, firefly luciferase, oxygen-dependent degradation, hypoxia-inducible factor alpha, erythropoietin, oral bioavailability, non-invasive imaging, mouse model, liver, kidney, gene expression profiling
- MeSH terms
- Animals, Cells, Cultured, Enzyme Inhibitors, Enzyme-Linked Immunosorbent Assay, Erythropoietin, Luciferases, Plasmids, Proteins, Molecular Probe Techniques, Cell Hypoxia, DNA Primers, DNA, Complementary, RNA, Untranslated, Models, Animal, Dioxygenases, Mice, Hypoxia-Inducible Factor 1, Hypoxia-Inducible Factor-Proline Dioxygenases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.